Ricardo F. Frausto

Mr. Ricardo F. Frausto

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 June 2019 in PLOS ONE
Verified
Journal Article
Open access
PDF file
RFRicardo F. Frausto
Ricardo F. Frausto
DCDoug D Chung
Doug D Chung
PBPayton M Boere
Payton M Boere
VSVinay S Swamy
Vinay S Swamy
HDHuong N V Duong
Huong N V Duong
AAAnthony J Aldave
Anthony J Aldave
The zinc finger e-box binding homeobox 1 (ZEB1) transcription factor is a master regulator of the epithelial to mesenchymal transition (EMT), and of the reverse mesenchymal to epithelial transition (MET) processes. ZEB1 plays an integral role in mediating cell state transitions during cell lineage specification, wound healing and disease. EMT/MET are characterized by distinct changes in molecular and cellular phenotype that are generally context-independent. Posterior polymorphous corneal dystrophy (PPCD), associated with ZEB1 insufficiency, provides a new biological context in which to understand and evaluate the classic EMT/MET paradigm. PPCD is characterized by a cadherin-switch and transition to an epithelial-like transcriptomic and cellular phenotype, which we study in a cell-based model of PPCD generated using CRISPR-Cas9-mediated ZEB1 knockout in corneal endothelial cells (CEnCs). Transcriptomic and functional studies support the hypothesis that CEnC undergo a MET-like transition in PPCD, termed endothelial to epithelial transition (EnET), and lead to the conclusion that EnET may be considered a corollary to the classic EMT/MET paradigm.

1 January 2016 in Journal of Ophthalmology
Verified
Journal Article
Open access
PDF file
BLBenjamin R. Lin
Benjamin R. Lin
RFRicardo F. Frausto
Ricardo F. Frausto
RVRosalind C. Vo
Rosalind C. Vo
SCStephan Y. Chiu
Stephan Y. Chiu
JCJudy L. Chen
Judy L. Chen
AAAnthony J. Aldave
Anthony J. Aldave
Purpose.To report the identification of the firstde novo UBIAD1missense mutation in an individual with Schnyder corneal dystrophy (SCD).Methods.A slit lamp examination was performed on a 47-year-old woman without a family history of corneal disorders. The proband’s parents, two sisters, and son were also examined and genomic DNA from all six individuals was collected. The exons and exon-intron boundaries ofUBIAD1were screened using Sanger sequencing. Identified mutations were screened for in 200 control chromosomes.In silicoanalysis predicted the impact of identified mutations on protein function and structure.Results.Slit lamp examination of the proband revealed findings consistent with SCD. Corneas of the family members appeared unaffected. Screening ofUBIAD1in the proband identified a novel heterozygous c.308C>T mutation, predicted to encode the missense amino acid substitution p.(Thr103Ile). This mutation was not identified in any of the family members or in 200 control chromosomes and was predicted to be damaging to normal protein function and structure.Conclusions.We present a novel heterozygousde novomissense mutation inUBIAD1, p.(Thr103Ile), identified in a patient with classic clinical features of SCD. This highlights the value of genetic testing in clinical diagnostic settings, even in the absence of a positive family history.

19 April 2018 in Ophthalmic Genetics
Verified
Journal Article
Open access
ACAleck E. Cervantes
Aleck E. Cervantes
KGKatherine M. Gee
Katherine M. Gee
MWMartha F. Whiting
Martha F. Whiting
RFRicardo F. Frausto
Ricardo F. Frausto
AAAnthony J. Aldave
Anthony J. Aldave
Purpose: To present the clinical and cytogenetic features of a previously unreported family with posterior amorphous corneal dystrophy (PACD) associated with a heterozygous deletion of the small leucine-rich proteoglycan (SRLP) genes on chromosome 12. Methods: Clinical characterization was performed using slit lamp biomicroscopic and optical coherence tomography (OCT) imaging. Genomic DNA was collected from affected and unaffected family members, and a cytogenomic array was used to identify copy number variations (CNV) present in the PACD locus. Results: Three members of a Guatemalan family presented with clinical characteristics consistent with PACD: bilateral posterior stromal lamellar opacification, decreased corneal curvature, and iridocorneal adhesions. OCT imaging demonstrated decreased corneal thickness and hyperreflectivity of the posterior third of the corneal stroma. CNV analysis confirmed the presumed clinical diagnosis of PACD by revealing a 0.304 Mb heterozygous deletion in the PACD locus on chromosome 12 that included the four SLRP genes (KERA, LUM, DCN, and EPYC) deleted in each of the PACD families in which CNV analysis has been reported. Conclusions: This is the first report of the OCT appearance of PACD and the second confirmation of a heterozygous deletion of chromosome 12q21.33 as the cause of PACD, highlighting the utility of array-based cytogenomics to confirm the suspected clinical diagnosis of PACD. As the smallest previously reported pathogenic deletion was 0.701 Mb, the 0.304-Mb deletion we report is the smallest identified to date and reduces the size of the PACD locus to 0.275 Mb.

12 February 2019 in bioRxiv
Verified
Preprint
Open access
PDF file
RFRicardo F. Frausto
Ricardo F. Frausto
DCDoug Chung
Doug Chung
PBPayton M. Boere
Payton M. Boere
VSVinay S. Swamy
Vinay S. Swamy
HDHuong Viet Nguyen Duong
Huong Viet Nguyen Duong
AAAnthony J. Aldave
Anthony J. Aldave
The zinc finger e-box binding homeobox 1 (ZEB1) transcription factor is a master regulator of the epithelial to mesenchymal transition (EMT), and of the reverse mesenchymal to epithelial transition (MET) processes. ZEB1 plays an integral role in mediating cell state transitions during cell lineage specification, wound healing and disease. EMT/MET are characterized by distinct changes in molecular and cellular phenotype that are generally context-independent. Posterior polymorphous corneal dystrophy (PPCD), associated with ZEB1 insufficiency, provides a new biological context in which to understand and evaluate the classic EMT/MET paradigm. PPCD is characterized by a cadherin-switch and transition to an epithelial-like transcriptomic and cellular phenotype, which we study in a cell-based model of PPCD generated using CRISPR-Cas9-mediated ZEB1 knockout in corneal endothelial cells (CEnCs). Transcriptomic and functional studies support the hypothesis that CEnC undergo a MET-like transition in PPCD, termed endothelial to epithelial transition (EnET), and lead to the conclusion that EnET may be considered a corollary to the classic EMT/MET paradigm.

1 September 2013 in Cytokine
Verified
Journal Article
Closed access
MHMeng-Ping Hsu
Meng-Ping Hsu
RFRicardo F. Frausto
Ricardo F. Frausto
SRStefan Rose-John
Stefan Rose-John
ICIain L Campbell
Iain L Campbell

1 September 2008 in Cytokine
Verified
Journal Article
Closed access
RFRicardo F. Frausto
Ricardo F. Frausto
GDGareth Denyer
Gareth Denyer
JSJürgen Scheller
Jürgen Scheller
SRStefan Rose-John
Stefan Rose-John
BJBrendan J. Jenkins
Brendan J. Jenkins
ICIain L. Campbell
Iain L. Campbell